Team Maureen


Cervical Cancer

Cervical cancer is killing women at a higher rate than previously thought

Women’s risk of dying from cervical cancer may be much greater than medical professionals originally thought, according to a new study.

updated: 1 year ago

Wider Racial Gap Found in Cervical Cancer Deaths

The death rate from cervical cancer in the United States is considerably higher than previously estimated and the disparity in death rates between black women and white women is significantly wider, according to a study published Monday in the journal Cancer.

updated: 4 years ago

Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond

Despite the declining incidence of cervical cancer as a result of the introduction of screening programs, globally it remains a leading cause of cancer-related death in women. Outcomes for patients who are diagnosed with anything but early-stage disease remain poor.

updated: 5 years ago

11 Things You Never Knew to Ask Your Gyno About Cervical Cancer

But just because this gynecologic cancer occurs less frequently doesn’t mean it’s less deadly.  In fact, cervical cancer was once the No. 1 leading cause of cancer death for women in the US. What’s worse? The disease is almost 100 percent preventable. This fact is especially chilling for Latinas, who have the highest incidence of cervical cancer and the second-highest death rate from the disease.

updated: 6 years ago

Half of young women unable to ‘locate vagina'

Half of young women are unable to properly label a vagina on a medical diagram, while 65 per cent have admitted they have a problem simply using the words vagina or vulva.

updated: 6 years ago

FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer

From the link:
Avastin works by interfering with the blood vessels that fuel the development of cancerous cells. The new indication for cervical cancer is approved for use in combination with chemotherapy drugs paclitaxel and cisplatin or in combination with paclitaxel and topotecan.

updated: 6 years ago

Study finds genomic differences in types of cervical cancer

A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type’s molecular idiosyncrasies.........
.....The research was supported by grants from the American Cancer Society, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Team Maureen Cervical Cancer Fund, and the Friends of Dana-Farber Cancer Institute.

updated: 6 years ago

Cervical Cancer

Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey

Human papillomavirus (HPV) vaccine uptake among US adolescents is primarily dependent on the intent of their parents. To the best of our knowledge, an analysis quantifying parental intent to initiate and complete the HPV vaccine series in the USA at both the national and state level has not been done. We aim to estimate parental intent to initiate and complete the HPV vaccine series at the national-level and state-level and to identify reasons for lack of intent to initiate and complete the vaccine series.

updated: 9 months ago